LEVOCARNITINE ORAL

LEVOCARNITINE ORAL was reported 3021 times

LEVOCARNITINE ORAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DYSGLOBULINAEMIA 3 0.1500
1 KERATOUVEITIS 5 0.1351
2 CYSTINOSIS 2 0.0952
3 MITOCHONDRIAL DNA DEPLETION 3 0.0857
4 DIFFUSION-WEIGHTED BRAIN MRI ABNORMAL 2 0.0741
5 HYPERAMMONAEMIC CRISIS 6 0.0561
6 MYOFASCITIS 3 0.0361
7 BASAL GANGLIA STROKE 5 0.0347
8 CARNITINE DEFICIENCY 5 0.0292
9 ZINC DEFICIENCY 5 0.0233
10 SEIZURE CLUSTER 15 0.0181
11 ANTICONVULSANT DRUG LEVEL ABNORMAL 3 0.0170
12 COPPER DEFICIENCY 2 0.0167
13 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 4 0.0159
14 RETINOGRAM ABNORMAL 4 0.0149
15 UREAPLASMA INFECTION 6 0.0147
16 CHANGE IN SEIZURE PRESENTATION 9 0.0139
17 MELAS SYNDROME 3 0.0139
18 VAGAL NERVE STIMULATOR IMPLANTATION 4 0.0131
19 AMMONIA ABNORMAL 5 0.0124
20 AMINO ACID LEVEL INCREASED 9 0.0121
21 HYPOPHOSPHATAEMIC OSTEOMALACIA 3 0.0114
22 MITOCHONDRIAL CYTOPATHY 5 0.0114
23 HYPERAMMONAEMIA 54 0.0108
24 SHUNT MALFUNCTION 3 0.0106
25 PRODUCT BARCODE ISSUE 4 0.0104
26 DRUG SPECIFIC ANTIBODY ABSENT 2 0.0098
27 MITOCHONDRIAL TOXICITY 8 0.0097
28 CATHETER SEPSIS 2 0.0096
29 PACKAGING DESIGN ISSUE 3 0.0091
30 EPILEPTIC ENCEPHALOPATHY 2 0.0090
31 PARAINFLUENZAE VIRUS INFECTION 13 0.0085
32 ARTERIOVENOUS FISTULA SITE COMPLICATION 5 0.0083
33 UPPER RESPIRATORY TRACT INFLAMMATION 10 0.0083
34 SPONTANEOUS HAEMATOMA 6 0.0080
35 NECROTISING OESOPHAGITIS 4 0.0080
36 ACETONAEMIA 2 0.0079
37 DILATED CARDIOMYOPATHY 8 0.0079
38 BLOOD MAGNESIUM INCREASED 7 0.0078
39 CYANOSIS CENTRAL 2 0.0077
40 AMMONIA INCREASED 37 0.0072
41 BLOOD HOMOCYSTEINE INCREASED 3 0.0070
42 ENTEROVIRUS INFECTION 6 0.0069
43 DEFIANT BEHAVIOUR 2 0.0065
44 INSULIN-LIKE GROWTH FACTOR INCREASED 9 0.0063
45 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 4 0.0062
46 STARVATION 5 0.0060
47 CHRONIC RESPIRATORY DISEASE 2 0.0057
48 DERMATITIS DIAPER 4 0.0057
49 INFANTILE SPASMS 4 0.0055
50 AORTIC VALVE SCLEROSIS 4 0.0055
51 SMALL FIBRE NEUROPATHY 4 0.0054
52 CENTRAL LINE INFECTION 2 0.0054
53 RHINOVIRUS INFECTION 21 0.0054
54 BURNOUT SYNDROME 3 0.0053
55 MYOCLONIC EPILEPSY 8 0.0053
56 HYPERAMMONAEMIC ENCEPHALOPATHY 9 0.0052
57 ESCHERICHIA BACTERAEMIA 12 0.0051
58 DISSEMINATED MUCORMYCOSIS 2 0.0051
59 PRODUCT PREPARATION ISSUE 33 0.0050
60 CHOROIDAL EFFUSION 4 0.0050
61 TONIC CONVULSION 7 0.0049
62 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 2 0.0048
63 ATONIC SEIZURES 4 0.0047
64 VENTRICULAR HYPOKINESIA 14 0.0044
65 PROPOFOL INFUSION SYNDROME 3 0.0043
66 INCISION SITE PAIN 5 0.0043
67 NEPHROCALCINOSIS 5 0.0042
68 DYSLALIA 3 0.0041
69 ORTHOPNOEA 13 0.0041
70 OTITIS MEDIA ACUTE 3 0.0041
71 SERRATIA INFECTION 3 0.0040
72 METABOLIC ENCEPHALOPATHY 12 0.0040
73 TRACHEITIS 3 0.0039
74 CYTOMEGALOVIRUS ENTEROCOLITIS 3 0.0039
75 BILIRUBIN CONJUGATED INCREASED 9 0.0038
76 GASTROINTESTINAL VIRAL INFECTION 4 0.0038
77 METAPNEUMOVIRUS INFECTION 3 0.0038
78 HYPERLACTACIDAEMIA 10 0.0037
79 EOSINOPHIL PERCENTAGE INCREASED 2 0.0037
80 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 14 0.0037
81 DYSCHROMATOPSIA 3 0.0036
82 ECZEMA EYELIDS 2 0.0036
83 BLOOD FIBRINOGEN DECREASED 4 0.0035
84 FOOD REFUSAL 3 0.0034
85 PULMONARY VALVE INCOMPETENCE 5 0.0034
86 STEROID DEPENDENCE 3 0.0034
87 ENDOTRACHEAL INTUBATION COMPLICATION 2 0.0034
88 GASTROSTOMY 5 0.0032
89 STATUS EPILEPTICUS 36 0.0032
90 RED BLOOD CELLS URINE POSITIVE 3 0.0031
91 METABOLIC DISORDER 18 0.0031
92 CARDIAC FAILURE CHRONIC 13 0.0030
93 LYMPHOCYTIC INFILTRATION 3 0.0030
94 BRONCHITIS VIRAL 2 0.0030
95 VARICELLA 7 0.0029
96 RENAL ARTERY STENOSIS 4 0.0029
97 PERTUSSIS 3 0.0029
98 CHRONIC FATIGUE SYNDROME 4 0.0029
99 FANCONI SYNDROME 4 0.0028
100 ADENOVIRUS INFECTION 8 0.0028
101 CLONIC CONVULSION 2 0.0027
102 B-CELL TYPE ACUTE LEUKAEMIA 2 0.0027
103 HYPOPROTEINAEMIA 5 0.0026
104 PNEUMONIA PSEUDOMONAL 4 0.0026
105 COAGULATION TEST ABNORMAL 2 0.0026
106 ENTEROCOLITIS 15 0.0026
107 FOLATE DEFICIENCY 3 0.0026
108 SEIZURE 300 0.0026
109 BLOOD KETONE BODY INCREASED 2 0.0026
110 BICYTOPENIA 5 0.0025
111 CIRCADIAN RHYTHM SLEEP DISORDER 2 0.0024
112 APPLICATION SITE WARMTH 3 0.0024
113 NOCTURNAL DYSPNOEA 3 0.0024
114 RENAL TUBULAR ACIDOSIS 5 0.0023
115 LIP INJURY 3 0.0023
116 AXIAL SPONDYLOARTHRITIS 2 0.0023
117 CANDIDA SEPSIS 2 0.0022
118 GLYCOSURIA 3 0.0022
119 BEHAVIOUR DISORDER 12 0.0022
120 VASCULAR DEVICE INFECTION 10 0.0022
121 CARBON DIOXIDE INCREASED 3 0.0022
122 SIALOADENITIS 3 0.0022
123 ENTEROCOLITIS INFECTIOUS 2 0.0022
124 MECHANICAL VENTILATION 4 0.0021
125 NOROVIRUS INFECTION 3 0.0021
126 OCULAR HYPERTENSION 4 0.0021
127 DROOLING 14 0.0020
128 DEVICE RELATED SEPSIS 4 0.0020
129 ELECTROENCEPHALOGRAM ABNORMAL 6 0.0019
130 KIDNEY TRANSPLANT REJECTION 9 0.0019
131 GENERALISED TONIC-CLONIC SEIZURE 31 0.0019
132 METABOLIC ALKALOSIS 3 0.0019
133 EPILEPSY 57 0.0019
134 HYPERPHOSPHATAEMIA 4 0.0019
135 ANTICONVULSANT DRUG LEVEL INCREASED 3 0.0019
136 TROPONIN I INCREASED 3 0.0018
137 COMPLEX PARTIAL SEIZURES 2 0.0018
138 CARDIOPULMONARY FAILURE 7 0.0018
139 CRYPTORCHISM 2 0.0018
140 SEIZURE LIKE PHENOMENA 3 0.0018
141 BRAIN OPERATION 4 0.0018
142 APLASIA PURE RED CELL 6 0.0017
143 HEPATIC ENCEPHALOPATHY 16 0.0017
144 FANCONI SYNDROME ACQUIRED 3 0.0017
145 PRESCRIBED UNDERDOSE 34 0.0017
146 DEVICE RELATED INFECTION 26 0.0017
147 DRUG WITHDRAWAL CONVULSIONS 3 0.0017
148 MYOPIA 4 0.0017
149 CONGESTIVE CARDIOMYOPATHY 7 0.0017
150 APPLICATION SITE DISCOMFORT 3 0.0017
151 CHRONIC RESPIRATORY FAILURE 2 0.0017
152 TACHYPNOEA 22 0.0016
153 MULTIPLE-DRUG RESISTANCE 5 0.0016
154 MYELOPATHY 3 0.0016
155 BRONCHIAL SECRETION RETENTION 2 0.0016
156 PETIT MAL EPILEPSY 8 0.0016
157 BLOOD CHLORIDE DECREASED 4 0.0015
158 ADJUSTMENT DISORDER 2 0.0015
159 PYELONEPHRITIS ACUTE 3 0.0015
160 PRODUCT ADMINISTRATION INTERRUPTED 12 0.0015
161 TRICUSPID VALVE INCOMPETENCE 12 0.0015
162 CLOSTRIDIUM DIFFICILE COLITIS 16 0.0015
163 ANION GAP INCREASED 2 0.0015
164 SKIN PAPILLOMA 6 0.0015
165 BRADYPNOEA 4 0.0015
166 HYPERURICAEMIA 6 0.0015
167 ACCIDENTAL POISONING 2 0.0015
168 BILIARY TRACT DISORDER 2 0.0014
169 ANAEMIA MACROCYTIC 3 0.0014
170 CEREBELLAR HAEMORRHAGE 2 0.0014
171 GASTROENTERITIS VIRAL 25 0.0014
172 RESPIRATORY SYNCYTIAL VIRUS INFECTION 12 0.0014
173 LIVER TRANSPLANT 5 0.0014
174 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
175 HYPOPHOSPHATAEMIA 10 0.0014
176 CENTRAL VENOUS CATHETERISATION 4 0.0013
177 NEPHROGENIC SYSTEMIC FIBROSIS 4 0.0013
178 COMPLICATIONS OF TRANSPLANTED KIDNEY 3 0.0013
179 PERIARTHRITIS 3 0.0013
180 ACIDOSIS 10 0.0013
181 CALCULUS URINARY 2 0.0013
182 DIASTOLIC DYSFUNCTION 4 0.0013
183 HAEMOLYTIC URAEMIC SYNDROME 3 0.0013
184 STREPTOCOCCAL INFECTION 7 0.0013
185 PNEUMONIA VIRAL 4 0.0013
186 LACUNAR INFARCTION 3 0.0013
187 STARING 3 0.0012
188 MYOSITIS 11 0.0012
189 OTITIS MEDIA 4 0.0012
190 INTRAVENTRICULAR HAEMORRHAGE 3 0.0012
191 HYPERNATRAEMIA 6 0.0012
192 PROTEIN URINE PRESENT 6 0.0012
193 PNEUMONIA ASPIRATION 30 0.0012
194 HYPERPARATHYROIDISM SECONDARY 3 0.0012
195 SPINAL PAIN 14 0.0012
196 METABOLIC ACIDOSIS 38 0.0012
197 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 6 0.0012
198 CEREBELLAR INFARCTION 2 0.0012
199 APPENDICITIS PERFORATED 3 0.0012
200 SEDATION COMPLICATION 3 0.0012
201 NEUTROPHIL COUNT INCREASED 12 0.0012
202 PARTIAL SEIZURES 6 0.0011
203 ALOPECIA AREATA 2 0.0011
204 WHITE BLOOD CELL DISORDER 3 0.0011
205 BLOOD UREA INCREASED 18 0.0011
206 BLOOD CHOLESTEROL DECREASED 2 0.0011
207 LUNG CONSOLIDATION 3 0.0011
208 ENDOTRACHEAL INTUBATION 3 0.0011
209 BLOOD IRON INCREASED 2 0.0011
210 PROTEIN TOTAL DECREASED 4 0.0011
211 PULMONARY CONGESTION 14 0.0011
212 CARDIAC FAILURE ACUTE 7 0.0010
213 BLOOD PARATHYROID HORMONE INCREASED 3 0.0010
214 CONCOMITANT DISEASE PROGRESSION 2 0.0010
215 PULMONARY HAEMORRHAGE 8 0.0010
216 SKIN ODOUR ABNORMAL 4 0.0010
217 HYPERVOLAEMIA 5 0.0010
218 HYPOTONIA 10 0.0010
219 HYPERCAPNIA 3 0.0010
220 VARICES OESOPHAGEAL 3 0.0010
221 MULTIPLE ORGAN DYSFUNCTION SYNDROME 28 0.0010
222 IRON DEFICIENCY ANAEMIA 9 0.0010
223 PORTAL HYPERTENSION 3 0.0010
224 INFUSION SITE EXTRAVASATION 6 0.0010
225 BODY TEMPERATURE FLUCTUATION 2 0.0010
226 BLOOD LACTIC ACID INCREASED 5 0.0009
227 OBESITY 15 0.0009
228 CATHETER SITE ERYTHEMA 2 0.0009
229 BACTERAEMIA 11 0.0009
230 HAEMODYNAMIC INSTABILITY 7 0.0009
231 HIGH DENSITY LIPOPROTEIN DECREASED 3 0.0009
232 RHINITIS ALLERGIC 4 0.0009
233 BLOOD ALBUMIN DECREASED 7 0.0009
234 SUDDEN CARDIAC DEATH 3 0.0009
235 PNEUMONIA BACTERIAL 8 0.0009
236 VIRAL INFECTION 29 0.0009
237 FUNCTIONAL GASTROINTESTINAL DISORDER 3 0.0009
238 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
239 TIBIA FRACTURE 4 0.0009
240 BRONCHIOLITIS 3 0.0009
241 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
242 RETCHING 18 0.0008
243 PRESCRIBED OVERDOSE 16 0.0008
244 GASTROENTERITIS 12 0.0008
245 BREATH ODOUR 2 0.0008
246 VITAMIN D DEFICIENCY 8 0.0008
247 FOOD INTOLERANCE 3 0.0008
248 THROMBOCYTOSIS 3 0.0008
249 SCOLIOSIS 5 0.0008
250 MALNUTRITION 9 0.0008
251 URINE OUTPUT DECREASED 7 0.0008
252 CATHETER SITE HAEMORRHAGE 2 0.0008
253 MITRAL VALVE INCOMPETENCE 9 0.0008
254 FACE INJURY 3 0.0008
255 SCREAMING 5 0.0008
256 ANGLE CLOSURE GLAUCOMA 2 0.0008
257 CHOLESTASIS 15 0.0008
258 COAGULOPATHY 13 0.0008
259 INCREASED UPPER AIRWAY SECRETION 4 0.0008
260 DEVELOPMENTAL DELAY 7 0.0008
261 FAILURE TO THRIVE 4 0.0008
262 FOOD CRAVING 4 0.0008
263 SERUM FERRITIN INCREASED 4 0.0008
264 CORONAVIRUS INFECTION 5 0.0008
265 MYOCLONUS 9 0.0008
266 HYPERLIPIDAEMIA 9 0.0008
267 CEREBRAL ATROPHY 3 0.0008
268 HYPERPHAGIA 3 0.0008
269 HYPOPHAGIA 19 0.0007
270 ENURESIS 3 0.0007
271 WRONG PRODUCT ADMINISTERED 5 0.0007
272 SHOCK 17 0.0007
273 LYMPHOCYTE COUNT DECREASED 13 0.0007
274 PERIPHERAL VENOUS DISEASE 3 0.0007
275 AUTISM SPECTRUM DISORDER 4 0.0007
276 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
277 ANAL HAEMORRHAGE 2 0.0007
278 ACUTE PULMONARY OEDEMA 4 0.0007
279 SLEEP TERROR 3 0.0007
280 REBOUND EFFECT 8 0.0007
281 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
282 FEBRILE BONE MARROW APLASIA 3 0.0007
283 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
284 HAND FRACTURE 5 0.0007
285 GRANULOCYTOPENIA 4 0.0007
286 PRODUCT DISPENSING ISSUE 3 0.0007
287 PRODUCT SUPPLY ISSUE 5 0.0007
288 DUODENAL ULCER HAEMORRHAGE 2 0.0007
289 BACTERIAL INFECTION 13 0.0007
290 HEPATIC FAILURE 21 0.0007
291 ALTERED STATE OF CONSCIOUSNESS 15 0.0007
292 ENCEPHALOPATHY 17 0.0007
293 OCULAR ICTERUS 3 0.0007
294 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
295 BLOOD CALCIUM INCREASED 6 0.0007
296 DYSPHEMIA 3 0.0007
297 HYPERTRIGLYCERIDAEMIA 4 0.0007
298 ARTHROPOD BITE 5 0.0007
299 BRAIN HERNIATION 2 0.0007
300 PROTHROMBIN TIME PROLONGED 4 0.0007
301 ATYPICAL PNEUMONIA 2 0.0007
302 MENINGITIS ASEPTIC 3 0.0007
303 BLOOD BILIRUBIN INCREASED 18 0.0007
304 EMERGENCY CARE 2 0.0007
305 ADRENAL INSUFFICIENCY 8 0.0007
306 ACUTE HEPATIC FAILURE 9 0.0007
307 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
308 HEPATOCELLULAR CARCINOMA 5 0.0007
309 TROPONIN INCREASED 5 0.0007
310 RESPIRATORY TRACT INFECTION 17 0.0007
311 DIFFUSE LARGE B-CELL LYMPHOMA 5 0.0006
312 PRODUCT DISTRIBUTION ISSUE 6 0.0006
313 LOW DENSITY LIPOPROTEIN INCREASED 5 0.0006
314 ILEUS 8 0.0006
315 HYPOALBUMINAEMIA 5 0.0006
316 SECRETION DISCHARGE 8 0.0006
317 BLOOD CREATININE DECREASED 2 0.0006
318 PRODUCT USE COMPLAINT 10 0.0006
319 SKIN ABRASION 3 0.0006
320 PRODUCT PRESCRIBING ERROR 15 0.0006
321 HYPERSOMNIA 18 0.0006
322 HEPATIC CYTOLYSIS 8 0.0006
323 CARDIOGENIC SHOCK 9 0.0006
324 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
325 SKIN INFECTION 7 0.0006
326 HUMERUS FRACTURE 3 0.0006
327 ATELECTASIS 6 0.0006
328 FRUSTRATION TOLERANCE DECREASED 5 0.0006
329 POST PROCEDURAL INFECTION 5 0.0006
330 BACTERIAL SEPSIS 2 0.0006
331 HYPERGLYCAEMIA 22 0.0006
332 APPETITE DISORDER 4 0.0006
333 FLUID INTAKE REDUCED 3 0.0006
334 MENINGITIS 4 0.0006
335 FEEDING DISORDER 12 0.0006
336 BLOOD CREATINE PHOSPHOKINASE INCREASED 17 0.0006
337 HEPATIC FUNCTION ABNORMAL 22 0.0006
338 FEBRILE NEUTROPENIA 39 0.0006
339 EYE MOVEMENT DISORDER 4 0.0006
340 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 10 0.0006
341 CERVICAL VERTEBRAL FRACTURE 2 0.0006
342 HYPERBILIRUBINAEMIA 6 0.0006
343 RESPIRATORY FAILURE 42 0.0006
344 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
345 TONSILLITIS 3 0.0006
346 MALABSORPTION 3 0.0006
347 SOMNOLENCE 115 0.0006
348 RESPIRATORY DEPRESSION 7 0.0006
349 BLOOD TEST ABNORMAL 8 0.0006
350 EMBOLIC STROKE 2 0.0006
351 GENERALISED OEDEMA 7 0.0006
352 SINUS TACHYCARDIA 8 0.0006
353 ANAL INCONTINENCE 5 0.0006
354 RHABDOMYOLYSIS 23 0.0006
355 FAECES SOFT 4 0.0005
356 RESPIRATORY DISTRESS 15 0.0005
357 AMYLASE INCREASED 2 0.0005
358 GRAND MAL CONVULSION 5 0.0005
359 PERSONALITY CHANGE 5 0.0005
360 CARDIAC DYSFUNCTION 2 0.0005
361 APPENDICITIS 5 0.0005
362 BLOOD POTASSIUM DECREASED 16 0.0005
363 ABNORMAL BEHAVIOUR 21 0.0005
364 HYPOCALCAEMIA 10 0.0005
365 OSTEOPENIA 8 0.0005
366 DERMATITIS CONTACT 6 0.0005
367 INSURANCE ISSUE 8 0.0005
368 BOWEL MOVEMENT IRREGULARITY 4 0.0005
369 CLAVICLE FRACTURE 2 0.0005
370 LIPASE INCREASED 4 0.0005
371 AFFECT LABILITY 5 0.0005
372 HYPERVENTILATION 3 0.0005
373 RALES 3 0.0005
374 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
375 APNOEA 4 0.0005
376 POOR QUALITY SLEEP 11 0.0005
377 SEPTIC SHOCK 22 0.0005
378 AZOTAEMIA 2 0.0005
379 SENSORY LOSS 4 0.0005
380 DERMATITIS ACNEIFORM 3 0.0005
381 DYSKINESIA 20 0.0005
382 EAR INFECTION 13 0.0005
383 POLYURIA 4 0.0005
384 ABNORMAL FAECES 4 0.0005
385 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 3 0.0005
386 INFLUENZA 54 0.0005
387 CHOLANGITIS 3 0.0005
388 JAUNDICE 13 0.0005
389 SWELLING OF EYELID 3 0.0005
390 BLOOD SODIUM DECREASED 9 0.0005
391 ASCITES 14 0.0005
392 PROTEINURIA 9 0.0005
393 INCONTINENCE 5 0.0005
394 PANCREATITIS 25 0.0005
395 BUNDLE BRANCH BLOCK LEFT 2 0.0005
396 LETHARGY 27 0.0005
397 HOSPITALISATION 72 0.0005
398 MENTAL STATUS CHANGES 13 0.0005
399 RESPIRATORY DISORDER 14 0.0005
400 PROCTALGIA 3 0.0005
401 ABNORMAL SENSATION IN EYE 2 0.0005
402 PHARYNGITIS STREPTOCOCCAL 5 0.0005
403 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
404 ASPIRATION 5 0.0005
405 HYPOXIA 16 0.0005
406 PURPURA 4 0.0005
407 FEMUR FRACTURE 14 0.0005
408 VENTRICULAR FIBRILLATION 5 0.0004
409 THERAPY PARTIAL RESPONDER 7 0.0004
410 CARDIOTOXICITY 4 0.0004
411 DECREASED APPETITE 104 0.0004
412 PANCYTOPENIA 25 0.0004
413 HAEMOLYTIC ANAEMIA 4 0.0004
414 PNEUMONIA 144 0.0004
415 ULCER HAEMORRHAGE 3 0.0004
416 BLOOD TESTOSTERONE DECREASED 3 0.0004
417 DISEASE COMPLICATION 2 0.0004
418 AGITATION 32 0.0004
419 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
420 UROSEPSIS 4 0.0004
421 HYPERTRANSAMINASAEMIA 3 0.0004
422 PYREXIA 148 0.0004
423 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
424 PHOTOPHOBIA 8 0.0004
425 UNDERDOSE 31 0.0004
426 SEASONAL ALLERGY 6 0.0004
427 DRUG LEVEL INCREASED 7 0.0004
428 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
429 FEAR OF INJECTION 3 0.0004
430 AGGRESSION 21 0.0004
431 ENDOMETRIOSIS 2 0.0004
432 SLEEP APNOEA SYNDROME 8 0.0004
433 ELECTROCARDIOGRAM QT PROLONGED 15 0.0004
434 NERVOUS SYSTEM DISORDER 13 0.0004
435 ACUTE RESPIRATORY FAILURE 8 0.0004
436 HYPERTHYROIDISM 6 0.0004
437 ENTEROCOCCAL INFECTION 2 0.0004
438 HAEMATURIA 14 0.0004
439 HEPATOMEGALY 4 0.0004
440 THERAPY CHANGE 4 0.0004
441 CARDIOMYOPATHY 6 0.0004
442 DEPRESSED LEVEL OF CONSCIOUSNESS 16 0.0004
443 VOMITING 189 0.0004
444 CELLULITIS 20 0.0004
445 BRAIN OEDEMA 5 0.0004
446 HYPOTHERMIA 4 0.0004
447 DYSLIPIDAEMIA 2 0.0004
448 BONE MARROW FAILURE 8 0.0004
449 COVID-19 69 0.0004
450 ALANINE AMINOTRANSFERASE INCREASED 24 0.0004
451 ENDOCARDITIS 2 0.0004
452 INITIAL INSOMNIA 4 0.0004
453 CACHEXIA 2 0.0004
454 FOOD ALLERGY 3 0.0004
455 INFUSION SITE PAIN 5 0.0004
456 LEUKOCYTOSIS 7 0.0004
457 PERITONITIS 8 0.0004
458 EJECTION FRACTION DECREASED 6 0.0004
459 SEPSIS 43 0.0004
460 VENTRICULAR EXTRASYSTOLES 4 0.0004
461 PRODUCT DOSE OMISSION ISSUE 113 0.0004
462 GASTROINTESTINAL INFLAMMATION 3 0.0004
463 APLASTIC ANAEMIA 2 0.0004
464 AFFECTIVE DISORDER 3 0.0004
465 MOUTH ULCERATION 8 0.0004
466 FULL BLOOD COUNT ABNORMAL 4 0.0004
467 CONJUNCTIVITIS 7 0.0004
468 HEPATIC STEATOSIS 7 0.0004
469 HYPOTHYROIDISM 12 0.0004
470 EATING DISORDER 8 0.0004
471 TRANSPLANT REJECTION 3 0.0004
472 COMPRESSION FRACTURE 2 0.0004
473 HEPATIC CIRRHOSIS 7 0.0004
474 ANAL ABSCESS 2 0.0004
475 BRUXISM 2 0.0004
476 LACTIC ACIDOSIS 12 0.0004
477 MUSCLE DISORDER 3 0.0004
478 NEURALGIA 9 0.0004
479 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
480 SKIN LACERATION 4 0.0004
481 PRODUCT DISPENSING ERROR 8 0.0004
482 IRRITABILITY 22 0.0004
483 TOOTH FRACTURE 4 0.0004
484 DENTAL CARIES 4 0.0004
485 CYSTIC FIBROSIS 2 0.0004
486 DEHYDRATION 48 0.0004
487 OCULAR DISCOMFORT 4 0.0004
488 EYE INFECTION 4 0.0004
489 VITAMIN D DECREASED 3 0.0004
490 DRUG-INDUCED LIVER INJURY 11 0.0004
491 CARDIAC VALVE DISEASE 2 0.0003
492 CARDIAC OPERATION 3 0.0003
493 NEPHROLITHIASIS 16 0.0003
494 ANURIA 3 0.0003
495 MULTI-ORGAN FAILURE 6 0.0003
496 HYPOKALAEMIA 16 0.0003
497 BLOOD URIC ACID INCREASED 2 0.0003
498 PRODUCT ADMINISTRATION ERROR 7 0.0003
499 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
500 SEDATION 9 0.0003
501 NEUTROPHIL COUNT DECREASED 14 0.0003
502 VASCULITIS 4 0.0003
503 TUMOUR LYSIS SYNDROME 3 0.0003
504 PRODUCT COMMUNICATION ISSUE 3 0.0003
505 SLEEP DISORDER 24 0.0003
506 DECREASED INTEREST 2 0.0003
507 LABORATORY TEST ABNORMAL 10 0.0003
508 CATARACT OPERATION 2 0.0003
509 EYE PAIN 19 0.0003
510 CARDIO-RESPIRATORY ARREST 14 0.0003
511 FREQUENT BOWEL MOVEMENTS 9 0.0003
512 CONVULSION 19 0.0003
513 OROPHARYNGEAL DISCOMFORT 3 0.0003
514 CONSTIPATION 72 0.0003
515 ILLNESS 34 0.0003
516 URINARY RETENTION 11 0.0003
517 NOCTURIA 4 0.0003
518 RESTLESSNESS 12 0.0003
519 LIVER INJURY 8 0.0003
520 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
521 HYPERCALCAEMIA 4 0.0003
522 ANKLE FRACTURE 5 0.0003
523 LUNG INFECTION 5 0.0003
524 ASPARTATE AMINOTRANSFERASE INCREASED 17 0.0003
525 PLATELET COUNT DECREASED 34 0.0003
526 ABORTION INDUCED 3 0.0003
527 INTESTINAL OBSTRUCTION 12 0.0003
528 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
529 INTENTIONAL DOSE OMISSION 9 0.0003
530 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
531 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
532 THERAPEUTIC RESPONSE DECREASED 19 0.0003
533 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
534 ENTERITIS 2 0.0003
535 OFF LABEL USE 273 0.0003
536 HYPERCHOLESTEROLAEMIA 3 0.0003
537 CHROMATURIA 7 0.0003
538 CARDIAC FLUTTER 2 0.0003
539 HEPATIC ENZYME INCREASED 21 0.0003
540 THROMBOTIC MICROANGIOPATHY 3 0.0003
541 ANGINA UNSTABLE 2 0.0003
542 HAEMORRHOIDS 6 0.0003
543 URINARY TRACT INFECTION 52 0.0003
544 ASPERGILLUS INFECTION 2 0.0003
545 LIGAMENT SPRAIN 3 0.0003
546 PERICARDIAL EFFUSION 7 0.0003
547 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
548 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
549 SALIVARY HYPERSECRETION 3 0.0003
550 BRAIN INJURY 3 0.0003
551 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
552 BRONCHIECTASIS 2 0.0003
553 FACE OEDEMA 5 0.0003
554 COLITIS ISCHAEMIC 2 0.0003
555 SINUS CONGESTION 4 0.0003
556 EYE IRRITATION 17 0.0003
557 HEMIPARESIS 5 0.0003
558 MOTOR DYSFUNCTION 3 0.0003
559 DISEASE RECURRENCE 14 0.0003
560 BODY TEMPERATURE INCREASED 6 0.0003
561 ABNORMAL LOSS OF WEIGHT 2 0.0003
562 LIVER DISORDER 13 0.0003
563 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
564 HAEMOGLOBIN DECREASED 30 0.0003
565 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
566 MUSCULOSKELETAL DISCOMFORT 5 0.0003
567 COLITIS 11 0.0003
568 ENCEPHALITIS 2 0.0003
569 DIARRHOEA 186 0.0003
570 PULMONARY HYPERTENSION 6 0.0003
571 FIBROMYALGIA 7 0.0003
572 TENDERNESS 3 0.0003
573 WEIGHT FLUCTUATION 3 0.0003
574 WHITE BLOOD CELL COUNT DECREASED 31 0.0003
575 DEFAECATION URGENCY 2 0.0003
576 OXYGEN SATURATION DECREASED 16 0.0003
577 RENAL PAIN 3 0.0003
578 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
579 HEPATOCELLULAR INJURY 4 0.0003
580 RED BLOOD CELL COUNT DECREASED 8 0.0003
581 RECTAL HAEMORRHAGE 12 0.0003
582 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
583 ABDOMINAL DISTENSION 29 0.0003
584 THROMBOCYTOPENIA 31 0.0003
585 OSTEOMYELITIS 5 0.0003
586 RESTLESS LEGS SYNDROME 5 0.0003
587 FLUID OVERLOAD 4 0.0003
588 COMA 13 0.0003
589 APPLICATION SITE PAIN 6 0.0003
590 INFECTION 39 0.0003
591 AGRANULOCYTOSIS 5 0.0003
592 IMMUNODEFICIENCY 4 0.0003
593 ANGER 9 0.0003
594 TREMOR 44 0.0003
595 FOOT FRACTURE 5 0.0003
596 AORTIC ANEURYSM 2 0.0003
597 NEUROPATHY PERIPHERAL 25 0.0003
598 OEDEMA PERIPHERAL 32 0.0003
599 INCREASED APPETITE 5 0.0003
600 GASTROOESOPHAGEAL REFLUX DISEASE 21 0.0003
601 NASOPHARYNGITIS 48 0.0003
602 BLOOD CREATININE INCREASED 17 0.0003
603 LOWER LIMB FRACTURE 5 0.0003
604 PRODUCT USE IN UNAPPROVED INDICATION 64 0.0003
605 ELECTROLYTE IMBALANCE 3 0.0003
606 PALLOR 7 0.0003
607 PNEUMONITIS 7 0.0003
608 DEVICE INFORMATION OUTPUT ISSUE 2 0.0003
609 GASTROINTESTINAL DISORDER 23 0.0003
610 CHOKING 5 0.0003
611 SPLENOMEGALY 3 0.0003
612 SURGERY 15 0.0003
613 CYANOSIS 4 0.0003
614 WEIGHT DECREASED 71 0.0003
615 COVID-19 PNEUMONIA 3 0.0003
616 EPISTAXIS 19 0.0003
617 PNEUMOTHORAX 4 0.0003
618 MEDICATION ERROR 14 0.0003
619 SCIATICA 4 0.0003
620 POLYNEUROPATHY 3 0.0003
621 WRIST FRACTURE 3 0.0003
622 CARDIAC FAILURE 20 0.0002
623 HYPONATRAEMIA 14 0.0002
624 TACHYCARDIA 22 0.0002
625 TASTE DISORDER 5 0.0002
626 DRUG INTERACTION 39 0.0002
627 PULMONARY OEDEMA 11 0.0002
628 ASPHYXIA 2 0.0002
629 MUSCLE SPASTICITY 3 0.0002
630 SINUSITIS 25 0.0002
631 BRONCHITIS 18 0.0002
632 PHARYNGITIS 3 0.0002
633 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
634 ACUTE CORONARY SYNDROME 2 0.0002
635 BLOOD PRESSURE DECREASED 16 0.0002
636 CYTOMEGALOVIRUS INFECTION 4 0.0002
637 OEDEMA 13 0.0002
638 NASAL CONGESTION 14 0.0002
639 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
640 MUSCULAR WEAKNESS 27 0.0002
641 CANDIDA INFECTION 4 0.0002
642 HALLUCINATION, VISUAL 5 0.0002
643 MUSCLE ATROPHY 3 0.0002
644 OVERDOSE 51 0.0002
645 URINARY INCONTINENCE 7 0.0002
646 BLOOD CHOLESTEROL INCREASED 11 0.0002
647 IMPAIRED WORK ABILITY 5 0.0002
648 LIVER FUNCTION TEST INCREASED 5 0.0002
649 UNRESPONSIVE TO STIMULI 6 0.0002
650 WEIGHT INCREASED 52 0.0002
651 ABDOMINAL PAIN 54 0.0002
652 APHASIA 7 0.0002
653 COUGH 65 0.0002
654 BLOOD MAGNESIUM DECREASED 2 0.0002
655 PLATELET COUNT INCREASED 3 0.0002
656 NODULE 3 0.0002
657 TREATMENT FAILURE 19 0.0002
658 FLATULENCE 13 0.0002
659 GASTRITIS 6 0.0002
660 HEART RATE DECREASED 8 0.0002
661 DISORIENTATION 9 0.0002
662 HEPATOTOXICITY 5 0.0002
663 CONDITION AGGRAVATED 68 0.0002
664 HEAD INJURY 7 0.0002
665 PERIPHERAL COLDNESS 3 0.0002
666 CARDIAC ARREST 18 0.0002
667 MOVEMENT DISORDER 7 0.0002
668 RESPIRATORY ARREST 6 0.0002
669 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
670 MUSCLE TWITCHING 5 0.0002
671 DIVERTICULITIS 6 0.0002
672 NECK PAIN 12 0.0002
673 ERYTHEMA MULTIFORME 2 0.0002
674 HYPOTENSION 43 0.0002
675 STOMATITIS 13 0.0002
676 MIDDLE INSOMNIA 4 0.0002
677 COGNITIVE DISORDER 10 0.0002
678 DEVICE OCCLUSION 3 0.0002
679 STAPHYLOCOCCAL INFECTION 7 0.0002
680 LYMPHOPENIA 3 0.0002
681 ARRHYTHMIA 10 0.0002
682 RENAL FAILURE 28 0.0002
683 BLOOD URINE PRESENT 4 0.0002
684 GAIT INABILITY 7 0.0002
685 ANGINA PECTORIS 6 0.0002
686 DIABETIC KETOACIDOSIS 5 0.0002
687 GLAUCOMA 4 0.0002
688 PULMONARY ARTERIAL HYPERTENSION 3 0.0002
689 MENTAL DISORDER 9 0.0002
690 INSOMNIA 55 0.0002
691 AUTOIMMUNE DISORDER 2 0.0002
692 ORAL HERPES 4 0.0002
693 ANAEMIA 39 0.0002
694 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
695 HEART RATE INCREASED 20 0.0002
696 HAEMATOCRIT DECREASED 4 0.0002
697 BLADDER DISORDER 2 0.0002
698 RHINORRHOEA 13 0.0002
699 HYPERKALAEMIA 7 0.0002
700 FATIGUE 155 0.0002
701 LACRIMATION INCREASED 6 0.0002
702 EMPHYSEMA 2 0.0002
703 ECONOMIC PROBLEM 3 0.0002
704 DEVICE BREAKAGE 8 0.0002
705 HEPATITIS 5 0.0002
706 THYROID DISORDER 3 0.0002
707 EMOTIONAL DISORDER 6 0.0002
708 OSTEOPOROSIS 8 0.0002
709 RIB FRACTURE 4 0.0002
710 ANAPHYLACTIC SHOCK 5 0.0002
711 LIMB DISCOMFORT 6 0.0002
712 GAIT DISTURBANCE 37 0.0002
713 DELUSION 3 0.0002
714 C-REACTIVE PROTEIN INCREASED 7 0.0002
715 BRAIN FOG 3 0.0002
716 NERVOUSNESS 10 0.0002
717 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 34 0.0002
718 PRODUCTIVE COUGH 9 0.0002
719 BALANCE DISORDER 16 0.0002
720 ABDOMINAL DISCOMFORT 31 0.0002
721 BLOOD POTASSIUM INCREASED 3 0.0002
722 DEEP VEIN THROMBOSIS 12 0.0002
723 BACK DISORDER 3 0.0002
724 BIPOLAR DISORDER 2 0.0002
725 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
726 BLOOD PRESSURE INCREASED 28 0.0002
727 MELAENA 4 0.0002
728 VENTRICULAR TACHYCARDIA 3 0.0002
729 HAEMATOCHEZIA 10 0.0002
730 ABNORMAL DREAMS 5 0.0002
731 PRODUCT USE ISSUE 34 0.0002
732 PLEURAL EFFUSION 11 0.0002
733 TRANSAMINASES INCREASED 4 0.0002
734 ABDOMINAL PAIN UPPER 37 0.0002
735 RENAL IMPAIRMENT 15 0.0002
736 PANCREATITIS ACUTE 4 0.0002
737 FALL 59 0.0002
738 CHOLECYSTECTOMY 2 0.0002
739 GENERAL PHYSICAL HEALTH DETERIORATION 20 0.0002
740 CAESAREAN SECTION 2 0.0002
741 SPEECH DISORDER 9 0.0002
742 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
743 ACUTE MYOCARDIAL INFARCTION 5 0.0002
744 DRUG ERUPTION 3 0.0002
745 NEUTROPENIA 23 0.0002
746 OCULAR HYPERAEMIA 8 0.0002
747 ATAXIA 2 0.0002
748 THIRST 3 0.0002
749 CHOLECYSTITIS 2 0.0002
750 ACCIDENT 2 0.0002
751 GOUT 3 0.0002
752 CONTUSION 16 0.0002
753 TOXICITY TO VARIOUS AGENTS 28 0.0002
754 PARAESTHESIA 26 0.0002
755 CRYING 6 0.0002
756 END STAGE RENAL DISEASE 3 0.0002
757 LOSS OF CONSCIOUSNESS 21 0.0002
758 CYTOPENIA 2 0.0002
759 CARDIOMEGALY 2 0.0002
760 DISEASE PROGRESSION 19 0.0002
761 DRY EYE 8 0.0002
762 LEUKOPENIA 8 0.0002
763 INTENTIONAL PRODUCT MISUSE 14 0.0002
764 SYNCOPE 16 0.0002
765 DERMATITIS ALLERGIC 2 0.0002
766 PULMONARY EMBOLISM 15 0.0002
767 HAEMATEMESIS 4 0.0002
768 FEELING JITTERY 3 0.0002
769 DYSPNOEA 89 0.0002
770 MOOD SWINGS 5 0.0002
771 POST PROCEDURAL COMPLICATION 3 0.0002
772 ADVERSE DRUG REACTION 14 0.0002
773 HIP FRACTURE 5 0.0002
774 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
775 ANOREXIA 2 0.0002
776 INFLAMMATION 8 0.0002
777 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
778 PRODUCT DOSE OMISSION 10 0.0002
779 KIDNEY INFECTION 3 0.0002
780 ADVERSE EVENT 14 0.0002
781 DISABILITY 3 0.0002
782 ASTHENIA 57 0.0002
783 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
784 SINUS DISORDER 3 0.0002
785 BLOOD PRESSURE ABNORMAL 3 0.0002
786 UPPER LIMB FRACTURE 3 0.0002
787 FUNGAL INFECTION 5 0.0001
788 SPINAL FRACTURE 3 0.0001
789 CARDIAC FAILURE CONGESTIVE 12 0.0001
790 MUSCULOSKELETAL STIFFNESS 13 0.0001
791 DISTURBANCE IN ATTENTION 8 0.0001
792 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
793 RASH PRURITIC 8 0.0001
794 LIMB INJURY 4 0.0001
795 MUSCLE SPASMS 27 0.0001
796 MOOD ALTERED 4 0.0001
797 MIGRAINE 14 0.0001
798 PRODUCT PREPARATION ERROR 3 0.0001
799 HOT FLUSH 11 0.0001
800 INFLUENZA LIKE ILLNESS 12 0.0001
801 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
802 POLLAKIURIA 6 0.0001
803 HAEMOPTYSIS 4 0.0001
804 RASH 62 0.0001
805 BLINDNESS UNILATERAL 2 0.0001
806 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
807 PAIN IN JAW 4 0.0001
808 JOINT INJURY 3 0.0001
809 IRRITABLE BOWEL SYNDROME 3 0.0001
810 PRODUCT SUBSTITUTION ISSUE 8 0.0001
811 SWELLING 13 0.0001
812 LIVER FUNCTION TEST ABNORMAL 4 0.0001
813 APATHY 2 0.0001
814 DYSSTASIA 4 0.0001
815 HYPERTENSION 29 0.0001
816 THROMBOSIS 11 0.0001
817 PERIPHERAL SWELLING 21 0.0001
818 DYSURIA 5 0.0001
819 PSYCHOTIC DISORDER 4 0.0001
820 NAUSEA 107 0.0001
821 DYSGEUSIA 10 0.0001
822 DRUG INTOLERANCE 13 0.0001
823 HEART RATE IRREGULAR 3 0.0001
824 PRODUCT AVAILABILITY ISSUE 3 0.0001
825 ILL-DEFINED DISORDER 8 0.0001
826 CHRONIC KIDNEY DISEASE 10 0.0001
827 DISCOMFORT 8 0.0001
828 MEMORY IMPAIRMENT 18 0.0001
829 DRUG DISPENSING ERROR 2 0.0001
830 FEELING HOT 8 0.0001
831 DRUG ADMINISTRATION ERROR 4 0.0001
832 OROPHARYNGEAL PAIN 12 0.0001
833 MYALGIA 22 0.0001
834 RENAL DISORDER 6 0.0001
835 BURNING SENSATION 9 0.0001
836 HYPOAESTHESIA 19 0.0001
837 THERAPY INTERRUPTED 9 0.0001
838 RASH ERYTHEMATOUS 6 0.0001
839 DRUG INEFFECTIVE 165 0.0001
840 BLOOD GLUCOSE DECREASED 6 0.0001
841 LOCALISED INFECTION 3 0.0001
842 HYPOGLYCAEMIA 6 0.0001
843 ANXIETY 35 0.0001
844 CEREBRAL INFARCTION 3 0.0001
845 LUNG DISORDER 6 0.0001
846 INFUSION RELATED REACTION 8 0.0001
847 AGEUSIA 3 0.0001
848 LIP SWELLING 4 0.0001
849 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
850 BONE PAIN 7 0.0001
851 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
852 ABDOMINAL PAIN LOWER 3 0.0001
853 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 24 0.0001
854 DIZZINESS 59 0.0001
855 CARDIOVASCULAR DISORDER 3 0.0001
856 HEADACHE 74 0.0001
857 FLUID RETENTION 6 0.0001
858 ACUTE KIDNEY INJURY 18 0.0001
859 CIRCULATORY COLLAPSE 2 0.0001
860 CHEST DISCOMFORT 12 0.0001
861 BLOOD GLUCOSE INCREASED 22 0.0001
862 DYSPHAGIA 11 0.0001
863 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
864 ANHEDONIA 3 0.0001
865 DEPRESSED MOOD 6 0.0001
866 CHEST PAIN 21 0.0001
867 LYMPHADENOPATHY 4 0.0001
868 DEATH 97 0.0001
869 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
870 CEREBRAL HAEMORRHAGE 4 0.0001
871 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
872 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
873 MOBILITY DECREASED 8 0.0001
874 THERAPY NON-RESPONDER 5 0.0001
875 TREATMENT NONCOMPLIANCE 6 0.0001
876 SKIN LESION 3 0.0001
877 TINNITUS 5 0.0001
878 SKIN DISCOLOURATION 5 0.0001
879 FEELING ABNORMAL 26 0.0001
880 BLOOD GLUCOSE ABNORMAL 2 0.0001
881 FEELING COLD 3 0.0001
882 BLISTER 6 0.0001
883 TARDIVE DYSKINESIA 3 0.0001
884 UNEVALUABLE EVENT 8 0.0001
885 DIABETES MELLITUS 8 0.0001
886 NO ADVERSE EVENT 19 0.0001
887 ERUCTATION 2 0.0001
888 DYSTONIA 2 0.0001
889 EAR PAIN 2 0.0001
890 ATRIAL FIBRILLATION 10 0.0001
891 PALPITATIONS 12 0.0001
892 HYPERSENSITIVITY 19 0.0001
893 DRUG DOSE OMISSION BY DEVICE 8 0.0001
894 MULTIPLE SCLEROSIS RELAPSE 7 0.0001
895 RENAL INJURY 3 0.0001
896 CYTOKINE RELEASE SYNDROME 2 0.0001
897 PREMATURE BABY 3 0.0001
898 EXTRA DOSE ADMINISTERED 4 0.0001
899 DRY MOUTH 8 0.0001
900 BLINDNESS 4 0.0001
901 CARDIAC DISORDER 9 0.0001
902 SWOLLEN TONGUE 3 0.0001
903 HAEMORRHAGE 10 0.0001
904 ROAD TRAFFIC ACCIDENT 4 0.0001
905 DERMATITIS 2 0.0001
906 BRADYCARDIA 5 0.0001
907 CYSTITIS 3 0.0001
908 CHILLS 11 0.0001
909 PRURITUS 36 0.0001
910 ACNE 7 0.0001
911 DEVICE LEAKAGE 4 0.0001
912 SWELLING FACE 6 0.0001
913 CHOLELITHIASIS 3 0.0001
914 OSTEONECROSIS 3 0.0001
915 ANAPHYLACTIC REACTION 5 0.0001
916 SKIN DISORDER 3 0.0001
917 URTICARIA 15 0.0001
918 DEVICE ISSUE 8 0.0001
919 THROAT IRRITATION 4 0.0001
920 PAIN IN EXTREMITY 26 0.0001
921 GASTRIC DISORDER 3 0.0001
922 SKIN IRRITATION 4 0.0001
923 DELIRIUM 3 0.0001
924 DYSPHONIA 5 0.0001
925 DEVICE MALFUNCTION 6 0.0001
926 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
927 WHEEZING 5 0.0001
928 MULTIPLE SCLEROSIS 4 0.0001
929 ERYTHEMA 17 0.0001
930 MALAISE 36 0.0001
931 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
932 DYSARTHRIA 3 0.0001
933 FLUSHING 8 0.0001
934 INTENTIONAL OVERDOSE 5 0.0001
935 THERAPY CESSATION 4 0.0001
936 HYPERHIDROSIS 10 0.0001
937 EXPOSURE VIA SKIN CONTACT 2 0.0001
938 DIPLOPIA 2 0.0001
939 SUICIDAL IDEATION 7 0.0001
940 ECZEMA 4 0.0001
941 DEPRESSION 17 0.0001
942 ARTHRALGIA 31 0.0001
943 INCORRECT DOSE ADMINISTERED 17 0.0001
944 CONFUSIONAL STATE 12 0.0001
945 PSORIATIC ARTHROPATHY 3 0.0001
946 VISUAL IMPAIRMENT 9 0.0001
947 DEMENTIA 2 0.0001
948 WITHDRAWAL SYNDROME 3 0.0001
949 HYPOACUSIS 3 0.0001
950 HERPES ZOSTER 4 0.0001
951 VAGINAL HAEMORRHAGE 3 0.0001
952 DEVICE DISLOCATION 3 0.0001
953 BACK PAIN 16 0.0001
954 PAIN 42 0.0001
955 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
956 ANGIOEDEMA 3 0.0001
957 CATARACT 4 0.0001
958 HALLUCINATION 5 0.0001
959 PRODUCT QUALITY ISSUE 9 0.0001
960 ALOPECIA 13 0.0001
961 EMOTIONAL DISTRESS 8 0.0001
962 CORONARY ARTERY DISEASE 2 0.0001
963 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
964 VISION BLURRED 9 0.0001
965 INJECTION SITE SWELLING 5 0.0001
966 EXPOSURE DURING PREGNANCY 4 0.0001
967 BONE DENSITY DECREASED 2 0.0001
968 AMNESIA 4 0.0001
969 EXPIRED PRODUCT ADMINISTERED 2 0.0001
970 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
971 CEREBROVASCULAR ACCIDENT 10 0.0001
972 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
973 JOINT SWELLING 7 0.0001
974 ARTHROPATHY 3 0.0001
975 DYSPNOEA EXERTIONAL 2 0.0001
976 ASTHMA 6 0.0001
977 ARTHRITIS 4 0.0001
978 DYSPEPSIA 5 0.0001
979 VERTIGO 3 0.0000
980 PSORIASIS 6 0.0000
981 MYOCARDIAL INFARCTION 8 0.0000
982 DRY SKIN 6 0.0000
983 INJECTION SITE PRURITUS 3 0.0000
984 COLITIS ULCERATIVE 2 0.0000
985 DRUG DOSE OMISSION 7 0.0000
986 INJECTION SITE ERYTHEMA 5 0.0000
987 DERMATITIS ATOPIC 2 0.0000
988 INJECTION SITE BRUISING 3 0.0000
989 PROSTATE CANCER 3 0.0000
990 DRUG EFFECT DECREASED 2 0.0000
991 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
992 SKIN EXFOLIATION 3 0.0000
993 BLADDER CANCER 2 0.0000
994 DRUG WITHDRAWAL SYNDROME 2 0.0000
995 INJECTION SITE PAIN 6 0.0000